Related Experiment Video
Updated: Feb 3, 2026

In Vitro Tumor Cell Rechallenge For Predictive Evaluation of Chimeric Antigen Receptor T Cell Antitumor Function
Published on: February 27, 2019
Establishment of a novel platform cell line for efficient and precise evaluation of T cell receptor functional
Soyoko Morimoto1, Fumihiro Fujiki2, Kenta Kondo3
1Department of Cancer Immunotherapy, Osaka University Graduate School of Medicine, Osaka, Japan.
Abstract:
Adoptive T-cell therapy with T cell receptor (TCR) -engineered T cells is an attractive strategy for cancer treatment and the success in this therapy is dependent on the functional avidity of the transduced TCRs against targeted tumor antigens. Therefore, the establishment of the methodology of the efficient and precise evaluation of TCR functional avidity has been awaited. Here, we show a novel platform cell line, named 2D3, which enables the functional avidity of transduced TCRs to be evaluated efficiently and precisely. In the 2D3, the precise TCR functional avidity of transduced TCRs is easily evaluable by the expression of green fluorescent protein (GFP) reporter gene driven by nuclear factor of activated T cells (NFAT) activation via TCR signaling. Four different TCRs of HLA-A*24:02-restricted Wilms' tumor gene 1 (WT1)-specific CD8+ cytotoxic T lymphocytes (CTLs) were transduced into 2D3 cells and the functional avidities of these four TCRs were evaluated. The evaluated functional avidity of these TCRs positively correlated with cell proliferation, cytokine production, and WT1-specific cytotoxicity of the TCR-transduced CD8+ T cells in response to WT1 antigen. These results showed that 2D3 cell line was a novel and stable tool useful for the efficient and precise evaluation of the functional avidity of isolated and transduced TCRs in developing TCR-based immunotherapy.
Insights
A new 2D3 cell line precisely evaluates T cell receptor (TCR) functional avidity for adoptive T-cell therapy. This tool aids in developing cancer immunotherapies by assessing TCR effectiveness against tumor antigens.
Area of Science:
- Immunology
- Oncology
- Cell Biology
Background:
- Adoptive T-cell therapy using T cell receptor (TCR)-engineered T cells is a promising cancer treatment.
- Therapeutic success hinges on the functional avidity of engineered TCRs against tumor antigens.
- A need exists for efficient and precise methods to evaluate TCR functional avidity.
Purpose of the Study:
- To introduce a novel platform cell line, 2D3, for efficient and precise evaluation of TCR functional avidity.
- To validate the utility of the 2D3 cell line in assessing TCRs targeting Wilms' tumor gene 1 (WT1).
Main Methods:
- Development of the 2D3 cell line, a reporter system utilizing green fluorescent protein (GFP) expression.
- TCR signaling activates nuclear factor of activated T cells (NFAT), driving GFP expression for avidity assessment.
- Transduction of four HLA-A*24:02-restricted WT1-specific CD8+ cytotoxic T lymphocyte (CTL) TCRs into 2D3 cells.
Main Results:
- The 2D3 cell line enabled efficient and precise evaluation of the functional avidity of the four transduced TCRs.
- Evaluated TCR functional avidity showed a positive correlation with T cell proliferation, cytokine production, and WT1-specific cytotoxicity.
- The 2D3 cell line demonstrated stability and utility in assessing TCR performance against the WT1 antigen.
Conclusions:
- The 2D3 cell line is a novel and stable tool for evaluating the functional avidity of TCRs.
- This platform facilitates the development of effective TCR-based immunotherapies for cancer treatment.
- Precise functional avidity assessment is crucial for optimizing TCR-engineered T cell therapies.
Related Concept Videos
Affinity and Avidity
Types of Receptors: Cell Surface Receptors
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Internal Receptors
Uncertainty in Measurement: Accuracy and Precision
Cell Adhesion Molecules - Types and Functions
CAM Families
The Integrin family of proteins is primarily involved...

